Sugi Predict

Sugi Predict / Compounds / SCHEMBL1771682

SCHEMBL1771682

SCHEMBL1771682

CC/C=C/CCOC(=O)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.64
▸ TDP1 Q9NUW8 3/20 0.58
▸ TSHR P16473 3/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ SLC6A2 P23975 2/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ F2 P00734 1/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.46
▸ ESR1 P03372 2/20 0.45
▸ CHRM1 P11229 1/20 0.45
▸ KDR P35968 1/20 0.45
▸ PKM P14618 1/20 0.45
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ ESR2 Q92731 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL130434 1.00 LMNA (0.64) LMNATDP1TSHRMAPK1SLC6A2
SCHEMBL130435 1.00 LMNA (0.64) LMNATDP1TSHRMAPK1SLC6A2
Benzoic Acid SCHEMBL1864558 0.95 LMNA (0.58) LMNATDP1TSHRMAPK1SLC6A2
(Z)-Hex-3-En-1-Yl Acetate SCHEMBL28969715 0.94 LMNA (0.57) LMNATDP1TSHRMAPK1SLC6A2
SCHEMBL30285512 0.90 LMNA (0.69) LMNATDP1TSHRMAPK1SLC6A2
SCHEMBL3751591 0.89 TDP1 (0.67) LMNATDP1TSHRMAPK1SMN1; SMN2
SCHEMBL3751588 0.89 TDP1 (0.67) LMNATDP1TSHRMAPK1SMN1; SMN2
SCHEMBL27491796 0.88 TDP1 (0.65) LMNATDP1TSHRMAPK1KMT2A
Ethyl Benzoate SCHEMBL29361886 0.86 LMNA (0.48) LMNATDP1TSHRMAPK1KMT2A
SCHEMBL30853560 0.85 LMNA (0.48) LMNATDP1TSHRMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4435080-B1 A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE PROCTER & GAMBLE (US) 2025-08-20 — — EP disclosed
US-12371642-B2 Benefit agent containing delivery particle THE PROCTER & GAMBLE COMPANY (US) 2025-07-29 — — US disclosed
EP-3955900-B1 POLYMERIC CAPSULES PROCTER & GAMBLE (US) 2025-07-23 — — EP disclosed
CN-120118001-A Aerobic nitriding method for olefin compounds 北京大学 2025-06-10 — — CN disclosed
WO-2025056470-A1 AQUEOUS-BASED PERFUME COMPOSITION JAFER ENTERPRISES R&D SL (ES) 2025-03-20 — — WO disclosed
WO-2024213455-A1 USE OF A COMPOSITION, IN PARTICULAR A FRAGRANCING COMPOSITION, COMPRISING DIETHYL SUCCINATE AND A TERTIARY AMINE JAFER ENTERPRISES R&D SL. (ES) 2024-10-17 — — WO disclosed
US-20240316523-A1 PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE PROCTER & GAMBLE COMPANY, THE 2024-09-26 — — US disclosed
EP-4435080-A1 A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE The Procter & Gamble Company (US) 2024-09-25 — — EP disclosed
EP-3596192-B1 BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES PROCTER & GAMBLE (US) 2024-05-15 — — EP disclosed
US-20230313084-A1 BENEFIT AGENT CONTAINING DELIVERY PARTICLE PROCTER & GAMBLE (US) 2023-10-05 — — US disclosed
US-20130039962-A1 ENCAPSULATES ENCAPSYS, LLC 2013-02-14 — — US disclosed
CN-102669196-A Plant composition for repelling mosquitoes and method for preparing same YOUFU WANG 2012-09-19 — — CN disclosed
EP-2468239-A1 Encapsulates Procter & Gamble International Operations SA (CH) 2012-06-27 — — EP disclosed
US-20120152268-A1 ENCAPSULATES PROCTER & GAMBLE COMPANY, THE 2012-06-21 — — US disclosed
US-20110152147-A1 ENCAPSULATES PROCTER & GAMBLE COMPANY, THE 2011-06-23 — — US disclosed
US-20110152146-A1 ENCAPSULATES THE PROCTER & GAMBLE COMPANY 2011-06-23 — — US disclosed
US-20110111999-A1 HIGH-EFFICIENCY PERFUME CAPSULES THE PROCTER & GAMBLE COMPANY 2011-05-12 — — US disclosed
US-7901724-B2 Fermented tea obtained by tea-rolling processing of tea material leaves and loquat leaves, and composition having extract contained in fermented tea as active component NAGASAKI PREFECTURAL GOVERNMENT (JP) 2011-03-08 — — US disclosed
US-20070190219-A1 Fermented Tea Obtained By Tea-Rolling Processing Of Tea Material Leaves And Loquat Leaves, And Composition Having Extract Contained In Fermented Tea As Active Component NAGASAKI PREFECTURAL GOVERNMENT (JP) 2007-08-16 — — US disclosed
JP-2006124444-A PERFUMERY COMPOSITION RESISTANT TO RUNNING WATER, AND COSMETIC SODA AROMATIC CO LTD 2006-05-18 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130039962-A1 ENCAPSULATES ABCB4, PPIB, FLNB LMNA 2056/4885TDP1 2006/4885TSHR 4882/4885
US-20110111999-A1 HIGH-EFFICIENCY PERFUME CAPSULES PLIN5, PORCN, PIGS LMNA 1780/4885TDP1 3587/4885TSHR 4659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.